fda bpc-157 compounding status 2026 ghk-cu approval π¨ The FDA just changed the rules on peptides β effective FDA Peptide Reclassification 2026: What
Description
Patients do not experience the intense hunger spikes associated with GHRP 6 or the cortisol elevation seen with hexarelin
That's where treatments like injectable B12 for humans come into play
It is the most widely studied of the three, with a large body of preclinical literature on tendons, ligaments, and gut tissue
Some prefer different injection sites, using BPC-157 near specific injuries and TB-500 subcutaneously in the abdomen
Just to give you a reference point, the RDA is like 24 IUs or something
